DOCSLIB.ORG

Stats Brochure-Cover-F.Indd

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Stats Brochure-Cover-F.Indd LIFE IN 2027 EXCELLENCE, INNOVATION, LEADERSHIP: RESEARCH AT THE UNIVERSITY OF TORONTO U of T RESEARCH BY THE NUMBERS U of T RESEARCH 1 A POWERFUL PARTNERSHIP BY THE NUMBERS 2 FACULTY EXCELLENCE Faculty Honours 3 RESEARCH FUNDING Research Funds Awarded Research Funds Awarded by Sector 4 FEDERAL FUNDING Federal Granting Council Funding to U15 Universities Canada Research Chairs at U15 Universities 5 FEDERAL FUNDING Canada Foundation for Innovation Funding to U15 Universities 6 PROVINCIAL FUNDING Ontario Ministry of Research and Innovation (MRI, now part of the Ministry of Economic Development and Innovation) Funding 7 INDUSTRY FUNDING Industry Funding to U15 Universities 8 INNOVATIONS Invention Disclosures 9 INNOVATIONS New Spin-off Companies 10 IMPACT Rankings on Publications and Citations World University Rankings 11 CONNAUGHT FUND 12 AWARDS AND HONOURS RESEARCHA POWERFUL FUNDING PARTNERSHIP The combination of U of T and the nine partner hospitals affi liated with the university creates one of the world’s largest and most innovative health research forces. More than 2,000 researchers and over 5,000 graduate students and postdoctoral fellows pursue the next vital steps in every area of health research imaginable. UNIVERSITY OF TORONTO SUNNYBROOK HEALTH ST. MICHAEL’S SCIENCES CENTRE HOSPITAL HOLLAND BLOORVIEW WOMEN’S COLLEGE KIDS REHABILITATION HOSPITAL A POWERFUL HOSPITAL PARTNERSHIP BAYCREST MOUNT SINAI HOSPITAL THE HOSPITAL CENTRE FOR ADDICTION FOR SICK CHILDREN AND MENTAL HEALTH UNIVERSITY HEALTH NETWORK* * Composed of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Hospital, and Toronto Rehabilitation Institute BY THE NUMBERS 1 FACULTY EXCELLENCE U of T researchers consistently win more prestigious awards than their peers at any other Canadian university. See the end of this booklet for a detailed list of awards and honours received by our faculty in recent years. FACULTY HONOURS (1980-2011) University of Toronto compared to awards held at other Canadian universities INTERNATIONAL AWARDS NATIONAL AWARDS American Academy of Arts & Sciences* Steacie Prize Gairdner International Award Molson Prize Guggenheim Fellows Killam Prize National Academies** Federal Granting Councils’ Royal Society Fellows Highest Awards**** Steacie Fellows Sloan Research Fellows American Association for the Killam Fellows Advancement of Science* ISI Highly Cited Researchers*** Royal Society of Canada Fellows 0 20406080100 0 20406080100 Percentage of awards held by U of T faculty Percentage of awards held by U of T faculty * Current members only ** The National Academies consist of: Institute of Medicine, National Academy of Engineering, National Academy of Sciences *** As of Sept 2011 **** Federal Granting Councils’ Highest Awards: NSERC: Gerhard Herzberg Canada Gold Medal for Science and Engineering; CIHR: Michael Smith Prize/Health Researcher of the Year; SSHRC: Gold Medal for Achievement in Research 2 RESEARCH AT THE UNIVERSITY OF TORONTO RESEARCH FUNDING U of T’s research funding has been increasing Research funding at U of T comes from a variety steadily over the past decade. of sources, in particular the federal and provincial governments. RESEARCH FUNDS AWARDED RESEARCH FUNDS AWARDED BY SECTOR (1998-99 to 2009-2010) (2009-2010) U of T including partner hospitals Total: $924M 1000 Federal Granting Councils Inter-Institutional Collaboration 36% 800 7% 600 Not-For-Profit 18% $ Million 400 Other Federal 15% 200 International 3% 0 Private Sector 6% 1998-99 1999-00 2000-01 2001-02 2002-03 2003-04 2004-05 2005-06 2006-07 2007-08 2008-09 2009-10 Other Government 1% Government of Ontario 15% All Sources Federal Granting Councils NOTE: Federal Granting Councils includes funding for Canada Research Chairs NOTE: Funding for affiliates and partner hospitals included BY THE NUMBERS 3 FEDERAL FUNDING U of T leads all Canadian universities in funding from the federal granting councils and the Canada Research Chairs program. FEDERAL GRANTING COUNCIL FUNDING CANADA RESEARCH CHAIRS AT U15 TO U15 UNIVERSITIES (2010-2011) UNIVERSITIES (2011-2012) U TORONTO U TORONTO UBC UBC McGill U McGill U U de Montréal U de Montréal U Alberta U Alberta U Ottawa U Laval U Laval U Ottawa McMaster U U Calgary U Western Ont. McMaster U U Calgary U Western Ont. U Waterloo U Waterloo Queenʼs U Queenʼs U Dalhousie U U Manitoba U Manitoba Dalhousie U U Saskatchewan U Saskatchewan 0 50 100 150 200 250 300 0 50 100 150 200 250 $ Millions Number of Chairs Allocated SSHRC NSERC CIHR NOTES: Excludes Networks of Centres of Excellence, Canada Research Chairs, Indirect Costs and funding DATA SOURCE: CRC website, updated March 2011 for the Canadian Light Source and Canadian Microelectronic Corporation. Funding for affiliates and partner NOTES: Montréal includes École Polytechnique and École des Hautes Études Commerciales (regular chairs only) hospitals counted with each university 4 RESEARCH AT THE UNIVERSITY OF TORONTO FEDERALRESEARCH FUNDING FUNDING U of T leads all Canadian universities in funding from the Canada Foundation for Innovation. CANADA FOUNDATION FOR INNOVATION FUNDING TO U15 UNIVERSITIES U TORONTO McGill U UBC U de Montréal U Alberta McMaster U U Laval U Western Ont. U Ottawa U Calgary U Waterloo Queenʼs U U Saskatchewan Dalhousie U U Manitoba 0 100 200 300 400 500 600 700 800 $Millions DATA SOURCE: CFI website, September 26, 2011 (funding since inception) NOTES: Funding for affiliates and partner hospitals included with each university National projects excluded BY THE NUMBERS 5 PROVINCIAL FUNDING U of T leads all Ontario universities in funding from the Ministry of Research and Innovation.* ONTARIO MINISTRY OF RESEARCH AND INNOVATION (MRI) FUNDING Top Ten Universities U TORONTO U Western Ont. McMaster U U Waterloo Queenʼs U U Ottawa U Guelph York U Carleton U Laurentian U 0 100 200 300 400 500 600 $Millions DATA SOURCE: Ministry of Research and Innovation (MRI), December 2011 NOTES: Limited to main competitive programs (funding since inception) Funding for affiliates and partner hospitals included with each university *As of October 2011, the Ministry of Research and Innovation has merged with the Ministry of Economic Development and Trade to form the Ministry of Economic Development and Innovation. 6 RESEARCH AT THE UNIVERSITY OF TORONTO INDUSTRY FUNDING U of T is among Canada’s leaders in industry-sponsored research. INDUSTRY FUNDING TO U15 UNIVERSITIES (2008-2009) U de Montréal U TORONTO U Alberta UBC U Laval Queenʼs U U Western Ont. McGill U U Calgary Dalhousie U U Ottawa McMaster U U Saskatchewan U Waterloo U Manitoba 0 1020304050607080 $Millions DATA SOURCE: CAUBO 2008-09 NOTES: Funding for affiliates and partner hospitals included with each university U Toronto data corrected for 1-year lag in reporting for affiliates McMaster: only entities consolidated included BY THE NUMBERS 7 INNOVATIONS U of T is among North America’s leaders in new invention disclosures. INVENTION DISCLOSURES (2006-2009) U.S. & Canadian universities California Inst Tech MIT Stanford U Wisconsin (Madison) U Washington U Illinois (Urbana & Chicago) Georgia Inst Tech U Michigan U Pennsylvania U TORONTO Johns Hopkins U Florida Columbia U Guelph SUNY Cornell Harvard U Colorado U Pittsburgh Purdue 0 500 1000 1500 2000 Number of new disclosures DATA SOURCE: AUTM Survey 2007 and 2008; AUTM STATT data 2009; Biodiscovery Toronto 2010 Summary Report on AUTM compatible indicators for the year 2009 NOTES: Where available, University of Toronto includes the following affiliate hospitals: Holland Bloorview Kids Rehabilitation Hospital, Centre for Addiction and Mental Health, Hospital for Sick Children, Mount Sinai Hospital, Sunnybrook Health Sciences Centre, and University Health Network U Washington includes Washington Research Foundation in all years University of California system excluded 8 RESEARCH AT THE UNIVERSITY OF TORONTO RESEARCHINNOVATIONS FUNDING U of T is among North America’s leaders in creating spin-off companies. NEW SPIN-OFF COMPANIES (2006-2009) U.S. & Canadian universities MIT U Utah California Inst Tech Columbia U Florida U Kentucky U Colorado U Washington U TORONTO Purdue Carnegie Mellon U Michigan Georgia Inst Tech U Illinois (Urbana & Chicago) Harvard Brigham Young Stanford SUNY Boston U Johns Hopkins 0 1020304050607080 Number of new spin-off companies DATA SOURCES: AUTM Survey 2007 and 2008; AUTM STATT data 2009; Biodiscovery Toronto 2010 Summary Report on AUTM compatible indicators for the year 2009 NOTES: Where available, University of Toronto includes the following affiliate hospitals: Holland Bloorview Kids Rehabilitation Hospital, Centre for Addiction and Mental Health, Hospital for Sick Children, Mount Sinai Hospital, Sunnybrook Health Sciences Centre, and University Health Network U Washington includes Washington Research Foundation in all years University of California system excluded BY THE NUMBERS 9 IMPACT U of T is one of the leading institutions in North America for publications and citations. RANKINGS ON PUBLICATIONS AND CITATIONS (2006-2010) CANADIAN NORTH AMERICAN NORTH AMERICAN PEERS – U15 PEERS* – PUBLIC (N=51) PEERS* – ALL (N=77) WORLD PUBLICATIONS CITATIONS PUBLICATIONS CITATIONS PUBLICATIONS CITATIONS UNIVERSITY All Fields 1 1 1 1 2 3 RANKINGS HEALTH & LIFE SCIENCES 1 1 1 1 2 3 Cardiac & Cardiovascular Systems 1 1 1 1 3 5 Infectious Diseases 1 1 6 6 10 12 The University of Toronto Molecular Biology & Genetics 1 1 1 2 2 5 ranks among the world’s Neuroscience & Behaviour 1 1 2 4 4 10 leading research-intensive Oncology 1 1 1 1 2 3 universities,
Load more

Recommended publications
  • Universidad Autónoma De Madrid
    UNIVERSIDAD AUTÓNOMA DE MADRID DEPARTAMENTO DE BIOLOGÍA MOLECULAR Identification and functional characterization of epigenetic determinants of pancreatic CSCs Sladjana Zagorac Madrid, 2015 DEPARTAMENTO DE BIOLOGÍA MOLECULAR FACULTAD DE CIENCIAS UNIVERSIDAD AUTÓNOMA DE MADRID Identification and functional characterization of epigenetic determinants of pancreatic CSCs Sladjana Zagorac Licenciatura en Biología Molecular y Fisiología Director de Tesis: Prof. Christopher Heeschen, M.D. PhD Centro de células madre en el cáncer y el envejecimiento Barts Instituto de Cancer (BCI) This thesis, submitted for the degree of Doctor of Philosophy at the Universidad Autónoma de Madrid, has been completed in the Stem Cells & Cancer Group at the Spanish National Cancer Research Centre (CNIO) and Centre for Stem Cells in Cancer and Ageing, Barts Cancer Instutute (BCI) under the supervision of Prof. Dr. Christopher Heeschen. Dedicated to my parents, my sister Ivana and my friends who always supported me. ACKNOWLEDGEMENTS It is strange to look back in time and see myself entering true the door of CNIO my first day in Christopher’s laboratory back in October 2010. For some maybe little and for other’s so much. Thank you Christopher for replaying to my email and opening me the door of your lab! It was just a start of an incredible journey that led me where I am now, and that will mark my next trails to run. So many people I need to mention and say thanks for their unconditional help and support. Enza thank you for accepting me as your student and for being patient with me. I will never forget how you would always tell me to think why I am doing things.
    [Show full text]
  • University of Toronto University-Wide Impact Presentation
    UNIVERSITY OF TORONTO UNIVERSITY-WIDE IMPACT PRESENTATION INTRO: .......................................................................................... 2 SECTION 1: GLOBAL FOOTPRINT .............................................. 3 SECTION 2: INNOVATION AND IMPACT .................................... 15 SECTION 3: EXCELLENCE AND LEADERSHIP IN SOCIETY ..... 31 Text is not editable on animation slides. Updated May 2021 ON-SCREEN IMAGE SPEAKER’S NOTES BEGINNING OF PRESENTATION [Good afternoon]. My name is [X], and I serve as [X] at the University of Toronto. Thank you for joining us [today]. [Today] I would like to take you through a presentation that speaks to the crucial role that U of T is honoured to play in our communities and our world. U of T is a world-leading university with three campuses in the Greater Toronto Area. We provide students with a comprehensive global education, produce life-changing research, and promote economic growth and social progress in our communities. I’m going to cover three aspects: • U of T’s Global Footprint • U of T’s Innovation and Impact • U of T’s Excellence and Leadership in Society Since its very early days, U of T has been fortunate to have forged connections with institutions around the world and to have welcomed faculty and students from elsewhere to become part of the U of T community. Today, U of T’s global footprint is significant. 2 SECTION 1 GLOBAL FOOTPRINT 3 ON-SCREEN IMAGE SPEAKER’S NOTES We are immensely proud of our worldwide alumni community. Over 630,000 U of T alumni live, work and contribute to civil society in more than 190 countries and territories. Few universities in the world can rival the cultural diversity of our student population.
    [Show full text]
  • Breast Density What Are the Implications for Cancer Screening?
    2018 ISSUE 2 Breast Density What are the implications for cancer screening? Key Concepts Fever in children returning from travel Choose Wisely Deciding on tests and treatments using the evidence base is Proud to celebrate 10 YEARS in Canada 42 million patients treated in clinical practice worldwide across all indications1 Thank you for your partnership over the last 10 years. We look forward to many more. Xarelto® is indicated for treatment of venous thromboembolic events For the treatment of VTE, Xarelto® is not recommended as an alternative (deep vein thrombosis [DVT], pulmonary embolism [PE]) and prevention to unfractionated heparin in patients with acute pulmonary embolus of recurrent DVT and PE. who are haemodynamically unstable, or who may receive thrombolysis or pulmonary embolectomy, since the safety and effi cacy of Xarelto® Xarelto® is indicated for the prevention of stroke and systemic have not been established in these clinical situations. embolism in patients with atrial fi brillation, in whom anticoagulation is appropriate. Xarelto® is not recommended for use in children less than 18 years of age. Xarelto® is indicated for the prevention of venous thromboembolic Consult the Xarelto® Product Monograph at http://bayer.ca/xarelto events (VTE) in patients who have undergone elective total hip for contraindications, warnings, precautions, adverse reactions, replacement (THR) or total knee replacement (TKR) surgery. interactions, dosing, and conditions of clinical use. The Product Monograph is also available by calling 1-800-265-7382. References: 1. Bayer data on fi le. 2. Xarelto® (rivaroxaban tablet) Product Monograph. Bayer Inc. May 9, 2018. ® TM see www.bayer.ca/tm-mc © 2018, Bayer Inc.
    [Show full text]
  • Radiation Medicine Program
    Radiation Medicine Program ANNUAL 2020 REPORT 2021 VALUES MISSION Innovation Advance exemplary radiation Excellence medicine through patient Collaboration care, research & education Accountability in partnership with CONTENTS Integrity our patients & community 4 A Message from the Chief 6 Program Overview 7 2020: The Year in Numbers 8 Strategic Roadmap to 2026 VISION 10 Clinical Care CURE EVOLVE 15 Quality & Safety Predictive Health & Precision Radiation Medicine. Advanced Particle Adaptive Radiotherapy Therapy & Theranostics 18 Education Personalized Care. 21 Research Global Impact. 26 Team RMP COMFORT & CONNECT Systems to Maximize CONFIDENCE Innovation & Wellbeing Technology-enabled Patient Experience Transformation A MESSAGE FROM THE CHIEF The Radiation Medicine Program (RMP) at the Princess Margaret Cancer Centre is committed to delivering the highest standard of patient care. Over the RMP’s innovative education programs continue to thrive and attract a diverse group of national and international attendees. Our award-winning Accelerated past year, our dynamic multidisciplinary team of radiation oncologists, medical physicists, radiation therapists, administrators, and support staff have worked Education Program (AEP) demonstrated extraordinary resourcefulness this past year, standing strong amidst the pandemic, and continuing to provide top- together to advance our vision of “Precision Radiation Medicine. Personalized Care. Global Impact.” RMP continues to uphold our foundational values of level education to a broad spectrum of learners.
    [Show full text]
  • Acceptance Speech by Professor Omar M. Yaghi
    Omar Yaghi’s Speech for 2017 Albert Einstein Science Award I want to thank the principals of the World Cultural Council, organizers of the Einstein World Award of Science Prize, and the generous hospitality of our hosts, Leiden University’s executive body, faculty, staff, and students. Please allow me to express my deepest appreciation to Lily Hernandez for her thoughtfulness and dedication to help bring all this together. I am deeply honored to join the ranks of distinguished scholars who were awarded this prize in years past. Ladies and Gentlemen, allow me to make the following brief remarks: As a child born to a refugee family, I firmly believe that each one of us is blessed with having an opportunity, a chance, a probability, to succeed in our chosen endeavor. I believe we are born with this opportunity and that we as individuals can work towards capturing it and, if we make the right decisions, we can grow and thrive. In other words, our ability to transform ourselves lies within us. I sincerely believe that this opportunity and the chance to succeed live in all of us. It is part of our DNA no matter who we are and where we come from. In my remarks here today, I wish to say something to those who may face at some point slim odds of success in their life, those who start at the lower rungs of the ladder, and those who experience difficulty and may feel sidelined by life’s twists and turns. I stand before you as a product of those slim odds and of a life of hardship such odds entail.
    [Show full text]
  • The Grand Challenges in the Chemical Sciences
    The Israel Academy of Sciences and Humanities Celebrating the 70 th birthday of the State of Israel conference on THE GRAND CHALLENGES IN THE CHEMICAL SCIENCES Jerusalem, June 3-7 2018 Biographies and Abstracts The Israel Academy of Sciences and Humanities Celebrating the 70 th birthday of the State of Israel conference on THE GRAND CHALLENGES IN THE CHEMICAL SCIENCES Participants: Jacob Klein Dan Shechtman Dorit Aharonov Roger Kornberg Yaron Silberberg Takuzo Aida Ferenc Krausz Gabor A. Somorjai Yitzhak Apeloig Leeor Kronik Amiel Sternberg Frances Arnold Richard A. Lerner Sir Fraser Stoddart Ruth Arnon Raphael D. Levine Albert Stolow Avinoam Ben-Shaul Rudolph A. Marcus Zehev Tadmor Paul Brumer Todd Martínez Reshef Tenne Wah Chiu Raphael Mechoulam Mark H. Thiemens Nili Cohen David Milstein Naftali Tishby Nir Davidson Shaul Mukamel Knut Wolf Urban Ronnie Ellenblum Edvardas Narevicius Arieh Warshel Greg Engel Nathan Nelson Ira A. Weinstock Makoto Fujita Hagai Netzer Paul Weiss Oleg Gang Abraham Nitzan Shimon Weiss Leticia González Geraldine L. Richmond George M. Whitesides Hardy Gross William Schopf Itamar Willner David Harel Helmut Schwarz Xiaoliang Sunney Xie Jim Heath Mordechai (Moti) Segev Omar M. Yaghi Joshua Jortner Michael Sela Ada Yonath Biographies and Abstracts (Arranged in alphabetic order) The Grand Challenges in the Chemical Sciences Dorit Aharonov The Hebrew University of Jerusalem Quantum Physics through the Computational Lens While the jury is still out as to when and where the impressive experimental progress on quantum gates and qubits will indeed lead one day to a full scale quantum computing machine, a new and not-less exciting development had been taking place over the past decade.
    [Show full text]
  • F. Sherwood Rowland Papers MS.F.029
    http://oac.cdlib.org/findaid/ark:/13030/kt638nf52f No online items F. Sherwood Rowland papers MS.F.029 Finding aid prepared by Dawn Schmitz, 2010; updated by Audra Eagle Yun and Alix Norton, 2012; updated by Kimberly Gallon, 2013; updated by Laura Uglean Jackson and Christine Kim, 2017. Processing of this collection was funded by the Andrew W. Mellon Foundation and administered by the Council on Library and Information Resources (CLIR), Cataloging Hidden Special Collections and Archives program. Special Collections and Archives, University of California, Irvine Libraries (cc) 2017 The UCI Libraries P.O. Box 19557 University of California, Irvine Irvine 92623-9557 [email protected] URL: http://special.lib.uci.edu F. Sherwood Rowland papers MS.F.029 1 MS.F.029 Contributing Institution: Special Collections and Archives, University of California, Irvine Libraries Title: F. Sherwood Rowland papers Creator: Rowland, F.S. Identifier/Call Number: MS.F.029 Physical Description: 204.8 Linear Feet(340 boxes and 2 oversized folders) Date (inclusive): 1928-2012 Date (bulk): 1980-2012 Abstract: F. Sherwood Rowland was the Donald Bren Research Professor of Chemistry in Earth System Science at the University of California, Irvine, beginning at UCI as a founding faculty member in 1964 and continuing as a professor and researcher until 2012. This collection documents his professional career in radiochemistry and atmospheric science. Included are materials documenting his research; awards including the Nobel Prize in chemistry (1995); professional service; and his global efforts to educate the public and policymakers about stratospheric ozone depletion, global climate change, and related environmental issues. Materials document the public controversies surrounding the chlorofluorocarbon (CFC) theory of ozone depletion and efforts to negotiate international agreements, including the Montreal Protocol, to ban CFC production.
    [Show full text]
  • Details September 2020, No. 5
    SEPTEMBER 2020 | No. 5 Details Your source for new Canadian stamps DEAR COLLECTORS COMING SOON! We care about your well-being At Canada Post, our priority during these challenging Don’t miss times continues to be the safety and health of our customers, employees and communities, while we a single issue work to provide Canadians with the essential services they depend on. Some of the temporary changes Check out our preview list made to the stamp program and the way we distribute and on-sale dates below and new issues to postal outlets remain in effect until further notice. Be sure to order your stamps online at mark your calendar. Then visit canadapost.ca/shop, so you don’t miss out. canadapost.ca to add these soon-to-be-released issues to Other changes have been made over the short term: your collection. • Print versions of Details special edition (Nos. 3 and 4) and No. 5 were sent to subscribers and are available online. Diwali • Stamp unveiling events will proceed in a virtual format. In-person events remain suspended until October 15 further notice. Mary Riter Hamilton This issue of Details features our Medical Groundbreakers October 28 stamps, highlighting six physicians and researchers whose innovative work is more evidence why Canada is a Holiday: Maud Lewis global leader in medical research and treatments that November 2 change lives. We’re also revealing our annual fundraising stamp for the Canada Post Community Foundation. The Christmas: The Nativity purchase of the stamp allows our customers to contrib- ute directly to grassroots and community programs that November 2 benefit Canadian children and youth – initiatives that need our support now more than ever.
    [Show full text]
  • Stem Cell Strategy by Establishing the Till & Mcculloch Medicines of Tomorrow Innovation Fund
    A Pre-Budget Submission to the House of Commons Standing Committee on Finance To Implement the Canadian Stem Cell Strategy By Establishing The Till & McCulloch Medicines of Tomorrow Innovation Fund James Price President & CEO Canadian Stem Cell Foundation February 9, 2016 EXECUTIVE SUMMARY Stem cells represent the biggest innovation in medicine of the last half century. These cells have the power to cure many diseases for which current medical practice can only provide symptomatic relief and chronic care – a reality that is straining health care systems in Canada and in countries around the globe. Stem cells are a hallmark of Canadian innovation. They were first discovered in Canada and Canada is one of the top three countries in stem cell R&D, with our scientists ranking among the best in the world. Recent investments, such as the Government’s $20-million commitment to establish a cell-manufacturing facility in Toronto and the $114-million Medicine By Design grant for the University of Toronto, will help Canada move forward. However, major commitments by competitor jurisdictions – most notably California, with its investment of $3 billion, and Japan, with an investment of $1 billion in stem cells and regenerative medicine -- challenge Canada’s leadership in this sector of the knowledge economy. Moreover, Canada lacks a national plan to succeed in the coming cell therapy and regenerative medicine boom. The Canadian Stem Cell Strategy -- created in consultation with 150 scientists, medical doctors, leaders from major health charities, industry experts, investors and philanthropists – will: • deliver up to 10 new curative therapies within 10 years; • transform health care and ease the strain on the health system; and • attract private investment and generate 12,000 jobs for Canadians.
    [Show full text]
  • Annual Report JULY 1, 2012 – JUNE 30, 2013
    Department of Surgery Annual Report JULY 1, 2012 – JUNE 30, 2013 Department of Surgery Annual Report JULY 1, 2012 – JUNE 30, 2013 R.S. Mclaughlin Professor And Chair Dr. J.T. Rutka Associate Chair And Vice-Chairs Dr. O. Rotstein Associate Chair Dr. D.A. Latter Vice-Chair, Education Dr. R.R. Richards Vice-Chair, Clinical Dr. B. Alman Vice-Chair, Research/A.J. Latner Professor and Chair of Orthopaedics Dr. R. McLeod Vice-Chair, Quality Dr. A. Kapus Associate Chair, Research Surgeons In Chief Dr. J.G. Wright The Hospital for Sick Children/Robert B. Salter Chair in Surgical Research Dr. J.S. Wunder Mount Sinai Hospital/Rubinoff-Gross Chair in Orthopaedics Dr. C. Compeau St. Joseph’s Health Centre Dr. O.D. Rotstein St. Michael’s Hospital Dr. A. Nathens Sunnybrook Health Sciences Centre Dr. G. Simone The Toronto East General Hospital Dr. S. Keshavjee University Health Network/James Wallace McCutcheon Chair in Surgery Dr. J.L. Semple Women’s College Hospital University Division Chairs Dr. C. Morshead Anatomy Dr. C. Caldarone Cardiac Surgery Dr. A. Smith General Surgery/Bernard and Ryna Langer Chair Dr. A. Lozano Leslie Dan Professor and Chair of Neurosurgery Dr. B. Alman A.J. Latner Professor and Chair of Orthopaedics Dr. C. Forrest Plastic Surgery (Interim Chair) Dr. T. Waddell F.G. Pearson/R.J. Ginsberg Chair in Thoracic Surgery Dr. N. Fleshner Martin Barkin Chair in Urological Research Dr. T. Lindsay Vascular Surgery Table of Contents 39th Gallie Day 3 St Michael’s Hospital 89 Chair’s Report 7 Division of Cardiac Surgery 90 Research Report
    [Show full text]
  • 2019 Impact Report
    2019 IMPACT REPORT Honouring Excellence. Preserving History. Inspiring Generations. We invite you to be inspired. FROM OUR BOARD CHAIR AND EXECUTIVE DIRECTOR It is an exciting time at the CMHF as we advance our mission thanks to vital and MISSION meaningful partnerships at many levels and the impacts of our programs in our 25th year of service are detailed well on the pages that follow. We are encouraged that our Recognize and celebrate capacity to do more going forward was strengthened this year with significant partner Canadian heroes whose investments: substantial operational support from the Canadian Medical Association work has advanced (CMA) for three years commencing in 2020 and program support from MD Financial health; inspire the Management across all our programs, including the Discovery Days in Health Sciences pursuit of careers in national presenting sponsorship. the health sciences. Change was also a theme for us in 2019 and it came in many forms: • After 16 years, we transitioned to temporary space at 100 Kellogg Lane in London, VISION ON in anticipation of developing our new Exhibit Hall space and offices in the North A Canada that honours Tower in 2020. This exciting, interactive destination will be home to the Children’s our medical heroes – Museum, an indoor adventure park, retail markets, a boutique hotel and an active those of the past, outdoor courtyard to name a few; an amazing co-location model that means more present and future. guests will experience the sense of pride we know comes with exploring our physical Laureate displays. • We undertook a review of our corporate identity and unveiled a new and contemporary brand, look and feel across all our programs.
    [Show full text]
  • News Release
    NEWS RELEASE: June 14, 2005 Health care leaders create Canada’s first national health advisory body The Canadian Academy of Health Sciences will give Government and the public comprehensive expertise and advice on health issues EDMONTON - When the President of the United States wants advice on a public health issue, he calls the United States’ National Academies. When the Prime Minister of Great Britain wants to seek similar counsel, he usually turns to the Royal Society of Britain. But when the Prime Minister of Canada wants similar advice, who does he call? Well, that’s not always entirely clear, given the more narrowly defined mandates of many Canadian organizations. Now, however, owing to a recent initiative by a group of leading health care leaders and researchers, the Prime Minister will be able to call the Canadian Academy of Health Sciences (CAHS), recently created to: • Develop informed, strategic assessments on urgent health issues; • Inform public policy on these issues; • Enhance Canada’s readiness to deal with global health issues; and, • Provide a recognized and authoritative Canadian health science voice internationally. According to one of the Academy’s key organizers, the establishment of the Academy is long over due—and all the more pressing given the potential global health threats to Canadians, most recently exemplified by the SARS threat. “Ask Canadians what they care about most, and they answer unequivocally: ‘health,’” explains University of Alberta Professor of Medicine Paul Armstrong, CAHS’s first president. “It makes sense, therefore, that Canada should have an organization that government—and Canadians—can turn to for sound, impartial advice and research on pressing health issues.” The organization will also have an international role to play, representing Canada’s interests abroad and working closely with other nations’ parallel agencies.
    [Show full text]